|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/36 | |
| A61K 39/395 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2222707 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08852770.0 |
| Europos patento paraiškos padavimo data | 2008-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/084336 |
| Data | 2008-11-21 |
| (87) | Numeris | WO 2009/067660 |
| Data | 2009-05-28 |
| (30) | Numeris | Data | Šalis |
| 989523 P | 2007-11-21 | US |
| (72) |
GRUBER, Andras, US
TUCKER, Erik, Ian, US
HANSON, Stephen, Raymond, US
GAILANI, David, US
|
| (73) |
Oregon Health & Science University,
3181 SW Sam Jackson Park Road, Portland, OR 97239,
US
Vanderbilt University, Office of Technology Transfer and Enterprise Development 305 Kirkland Hall, Nashville, TN 37240, US |
| (54) | ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF |
| ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF |